RegenMed maintains long-term relationships with its Circle Members. It develops sustained value for them. These are the relationships for which industry makes large budget allocations each year.
RegenMed acts as an ethical intermediary between clinicians and industry. It helps identify influencers, new product indications, changes in patient expectations, and better approaches to education and training.
Circles convert healthcare data into actionable evidence, the principal objective of most research. RegenMed supports investigator-initiated study proposals and execution, medical society grants, direct access to indication-specific Circle registries, IRB and medical ethics committee processes, publication, and other high quality research initiatives.
Circles efficiently generate statistically significant datasets for post-market surveillance, IDEs, INDs, claims support and other legal/regulatory issues. RegenMed works with industry Clients to identify those objectives, recruit suitable Circle Members (investigators, scientific experts and other), and implement a cost-effective program with established KPIs.
Many Circles represent de facto innovation centers. Circle Members develop evidence on the safest and most efficacious use cases for a given treatment protocol and/or product. They confirm or disprove initial hypotheses, improve, measure again and continue to improve. All in the real-world setting. RegenMed processes help ensure that these data, and the Circle Members generating them, can help drive industry objectives.
RegenMed processes help industry navigate the transition from off-label use of a product as practice of medicine to investigational use. Circles generate real-world evidence in both contexts, providing a low-cost yet statistically significant foundation for developing IND, IDE and 510-K submissions.
Major medical product companies maintain substantial budgets for direct-to-consumer marketing. Industry clients of all sizes can develop patient branding much more affordably, and in a much more targeted manner, through Circles-based practice websites, digital front-doors, social media, and other publication/influence channels.
Regulators and payers are emphasizing health equity and social determinants of health elements of value-based care. RegenMed processes take advantage of the low cost and excellent user experience of Circles to capture clinically-significant data from underserved populations, and convert those data into quality care.